Huaxia Heng Tian
VC Fund
Hangzhou, China
Huaxia Heng Tian is a venture capital firm that specializes in equity investment, fund management, and family wealth management. Huaxia Heng Tian is a well-known angel investor, financial veteran, and former member of the political elite. It is made up of a team with a strategic vision, worldwide experience, and strong technology application andtransformation capabilities.
- Total investments:
- 22
- Last investment:
- Lead investor:
- 14%
Last updated:
For AI agents: llms.txt
Industries Huaxia Heng Tian invests in
Stages Huaxia Heng Tian invests in
Countries Huaxia Heng Tian invests in
Investment Focus
Industry
- Information Technology 7 (32%)
- Software 3 (14%)
- Medical 2 (9%)
- Internet 2 (9%)
- Health Care 2 (9%)
Stage
- Venture - Series Unknown 8 (36%)
- Series A 3 (14%)
- Series B 3 (14%)
- Seed 2 (9%)
- Post-IPO Equity 2 (9%)
Country
- China 11 (50%)
- United States 1 (5%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Logicbit Technology
|
Logic Bit is a developer of large-scale superconducting quantum computing devices. Logic Bit has established technological reserves that encompass the full process of superconducting quantum chip design, micro-nano processing, radio frequency control, quantum computation, and simulation. | Series A / Jul 09, 2026 | |
|
Logicbit Technology
|
Logic Bit is a developer of large-scale superconducting quantum computing devices. Logic Bit has established technological reserves that encompass the full process of superconducting quantum chip design, micro-nano processing, radio frequency control, quantum computation, and simulation. | Seed / Mar 17, 2026 | |
SpacemiT
|
SpacemiT is a computing chip company developing natively integrated cloud-edge-device architecture. It focuses on building RISC-V high-performance CPUs and providing computing solutions with integrated hardware and software optimization. The company's mission is to be the cornerstone of computing power in the digital age, driven to become asignificant global computing powerhouse. | $86.1M / Series B / Jan 15, 2026 | |
Juyue Gear
|
Juyue Gear is a manufacturer specializing in automotive gears and dedicated to the research and design of precision components. | Series A / Jan 09, 2026 | |
Zhongneng Optoelectronics Technology
|
Zhongneng Optoelectronics Technology is a provider of thin-film optoelectronic technology. | Series B / Nov 24, 2025 | |
|
Logicbit Technology
|
Logic Bit is a developer of large-scale superconducting quantum computing devices. Logic Bit has established technological reserves that encompass the full process of superconducting quantum chip design, micro-nano processing, radio frequency control, quantum computation, and simulation. | Seed / Oct 14, 2025 | |
Ultron Photonics
|
Altra Photonics is committed to developing the world's most advanced femtosecond laser systems, providing you with reliable and stable ultrafast lasers and various ultrafast laser machines, devices and application solutions to help you create higher value. | Series C / Nov 21, 2024 | |
|
Zhongneng Optoelectronics Technology
|
Zhongneng Optoelectronics Technology is a provider of thin-film optoelectronic technology. | Venture - Series Unknown / Dec 05, 2022 | |
|
Bubble Mart
|
Beijing Bubble Mart Cultural and Creative Co., Ltd. was established in 2010. In the past ten years of development, Bubble Mart has focused on four areas: artist mining, IP incubation and operation, consumer contact, and the promotion and cultivation of trendy play culture. A comprehensive operation platform for the entire industry chain. | Venture - Series Unknown / Mar 17, 2022 | |
|
Ruishun Biotechnology
|
Ruishun Bio was established in February 2012, focusing on the development of off-the-shelf universal DNT immune cells. A complete cell production, preparation, and quality control system has been established, and the pipeline for relapsed and refractory acute myeloid leukemia has entered clinical phase I, making it the world's first non-geneediting general-purpose tumor immune cell product . The company will further expand the indication scope of DNT cells on the basis of continuous optimization of the existing process, so as to solve the unmet clinical needs with better efficacy. | Venture - Series Unknown / Mar 16, 2022 | |
| See all 22 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Huaxia Heng Tian invest in?
Huaxia Heng Tian invests primarily in Information Technology, Software and Medical startups, most often at Venture - Series Unknown and Series A stage. Most of the 22 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Huaxia Heng Tian last invest?
The most recent investment recorded for Huaxia Heng Tian closed in Jul 2026. Shizune tracks 22 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
